Cargando…
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs
Chikungunya virus (CHIKV) is a globally spreading alphavirus against which there is no commercially available vaccine or therapy. Here we use a genome-wide siRNA screen to identify 156 proviral and 41 antiviral host factors affecting CHIKV replication. We analyse the cellular pathways in which human...
Autores principales: | Karlas, Alexander, Berre, Stefano, Couderc, Thérèse, Varjak, Margus, Braun, Peter, Meyer, Michael, Gangneux, Nicolas, Karo-Astover, Liis, Weege, Friderike, Raftery, Martin, Schönrich, Günther, Klemm, Uwe, Wurzlbauer, Anne, Bracher, Franz, Merits, Andres, Meyer, Thomas F., Lecuit, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865845/ https://www.ncbi.nlm.nih.gov/pubmed/27177310 http://dx.doi.org/10.1038/ncomms11320 |
Ejemplares similares
-
RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals
por: Lesch, Markus, et al.
Publicado: (2019) -
Properties and use of novel replication-competent vectors based on Semliki Forest virus
por: Rausalu, Kai, et al.
Publicado: (2009) -
Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011) -
Mutations at the palmitoylation site of non-structural protein nsP1 of Semliki Forest virus attenuate virus replication and cause accumulation of compensatory mutations
por: Žusinaite, Eva, et al.
Publicado: (2007) -
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
por: Gläsker, Sabine, et al.
Publicado: (2013)